| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Dec'17 |
|---|---|---|---|---|---|---|
ASSETS | ||||||
Current assets | ||||||
Cash | ||||||
4,349 | 1,690 | 3,214 | 4,092 | 5,166 | 282 | 1,230 |
Marketable securities | ||||||
490 | 803 | 804 | - | - | - | - |
Prepaid expenses | ||||||
56 | 110 | 113 | 101 | 88 | 12 | - |
Deferred offering cost | ||||||
- | 30 | - | 32 | - | 206 | - |
Total current assets | ||||||
4,896 | 2,635 | 4,133 | 4,226 | 5,254 | 501 | 1,230 |
Property and equipment, net | ||||||
0 | 1 | 1 | 1 | 1 | 2 | 3 |
Investment in joint venture | ||||||
250 | - | - | - | - | - | - |
Restricted cash | ||||||
200 | 200 | 200 | 200 | 200 | - | - |
Total assets | ||||||
5,347 | 2,836 | 4,334 | 4,427 | 5,456 | 503 | 1,233 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current liabilities | ||||||
Accounts payable | ||||||
515 | 403 | 17 | 212 | 70 | 142 | 47 |
Accrued expenses | ||||||
7 | 36 | 7 | 27 | 17 | 206 | 1 |
Total current liabilities | ||||||
523 | 440 | 25 | 239 | 87 | 348 | 49 |
Total liabilities | ||||||
523 | 440 | 25 | 239 | 87 | 348 | 49 |
Stockholders' equity | ||||||
Common stock, $0.0001 par value, 75,000,000 shares authorized, 11,593,701 and 10,119,844 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively | ||||||
1 | 1 | 1 | 0 | 0 | 0 | 0 |
Additional paid-in-capital | ||||||
18,865 | 14,610 | 12,612 | 10,795 | 10,707 | 4,665 | 3,199 |
Accumulated deficit | ||||||
-14,042 | -12,215 | -8,303 | -6,607 | -5,340 | -4,511 | -2,015 |
Total stockholders' equity | ||||||
4,824 | 2,396 | 4,309 | 4,188 | 5,368 | 154 | 1,184 |
Total liabilities and stockholders' equity | ||||||
5,347 | 2,836 | 4,334 | 4,427 | 5,456 | 503 | 1,233 |
Series A Convertible Preferred Stock | ||||||
Preferred stock value | ||||||
- | - | - | - | - | 0 | 0 |